BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2414908)

  • 1. Detailed immunologic analysis of the structural polypeptides of rubella virus using monoclonal antibodies.
    Waxham MN; Wolinsky JS
    Virology; 1985 May; 143(1):153-65. PubMed ID: 2414908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.
    Wolinsky JS; McCarthy M; Allen-Cannady O; Moore WT; Jin R; Cao SN; Lovett A; Simmons D
    J Virol; 1991 Aug; 65(8):3986-94. PubMed ID: 1712855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus.
    Hunt AR; Roehrig JT
    Virology; 1985 Apr; 142(2):334-46. PubMed ID: 2414904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of the rubella virus proteins.
    Dorsett PH; Miller DC; Green KY; Byrd FI
    Rev Infect Dis; 1985; 7 Suppl 1():S150-6. PubMed ID: 4001722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model of the structural organization of rubella virions.
    Waxham MN; Wolinsky JS
    Rev Infect Dis; 1985; 7 Suppl 1():S133-9. PubMed ID: 4001720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody.
    Trudel M; Nadon F; Séguin C; Amarouch A; Payment P; Gillam S
    J Virol Methods; 1985 Dec; 12(3-4):243-50. PubMed ID: 2422194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells.
    Cordoba P; Grutadauria S; Cuffini C; Zapata M
    Viral Immunol; 2000; 13(1):83-92. PubMed ID: 10733171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein.
    Schmaljohn AL; Kokubun KM; Cole GA
    Virology; 1983 Oct; 130(1):144-54. PubMed ID: 6195815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies directed to E1 glycoprotein of rubella virus.
    Umino Y; Sato TA; Katow S; Matsuno T; Sugiura A
    Arch Virol; 1985; 83(1-2):33-42. PubMed ID: 2578781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.
    Green KY; Dorsett PH
    J Virol; 1986 Mar; 57(3):893-8. PubMed ID: 2419590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of rubella virus glycoprotein E1 in yeast cells.
    Wen H; Wang Z
    Intervirology; 2005; 48(5):321-8. PubMed ID: 15956800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic differences between two viruses, isolated in Japan and Korea, that cause hemorrhagic fever with renal syndrome.
    Yamanishi K; Dantas JR; Takahashi M; Yamanouchi T; Domae K; Takahashi Y; Tanishita O
    J Virol; 1984 Oct; 52(1):231-7. PubMed ID: 6207309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against avian reticuloendotheliosis virus: identification of strain-specific and strain-common epitopes.
    Cui ZZ; Lee LF; Silva RF; Witter RL
    J Immunol; 1986 Jun; 136(11):4237-42. PubMed ID: 2422277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical identification of rubella virus hemagglutinin.
    Waxham MN; Wolinsky JS
    Virology; 1983 Apr; 126(1):194-203. PubMed ID: 6845655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Chong P; Tripet B; Brush B; Gillam S
    Virology; 1992 Aug; 189(2):483-92. PubMed ID: 1379391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies to individual proteins of rubella virus.
    Loo TW; MacDonald I; Clarke DM; Trudel M; Tingle A; Gilam S
    J Virol Methods; 1986 May; 13(2):149-59. PubMed ID: 3734013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and antigenic characteristics and synthesis of rubella virus structural proteins.
    Pettersson RF; Oker-Blom C; Kalkkinen N; Kallio A; Ulmanen I; Kääriäinen L; Partanen P; Vaheri A
    Rev Infect Dis; 1985; 7 Suppl 1():S140-9. PubMed ID: 4001721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.
    Wolinsky JS; Sukholutsky E; Moore WT; Lovett A; McCarthy M; Adame B
    J Virol; 1993 Feb; 67(2):961-8. PubMed ID: 7678312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence variation and biological activity of rubella virus isolates.
    Londesborough P; Ho-Terry L; Terry G
    Arch Virol; 1995; 140(3):563-70. PubMed ID: 7537491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.